To gain a more thorough understanding of metformin’s effects on HNSCC CSCs, we performed RT-qPCRs for JLO-1 cells to measure changes in expression of stem cell markers CD44, BMI-1, Oct-4, and Nanog after exposure to metformin. Here, BMI1 is linked to head and neck squamous cell carcinoma.